Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02384226 · ClinicalTrials.gov registry record
User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
A clinical trial of Preeclampsia and Gestational Hypertension, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 26
- Enrollment target
- 1
- Study location
NCT02384226: Completed study of Preeclampsia and Gestational Hypertension, sponsored by University of Colorado, Denver.
NCT02384226 is a study of Preeclampsia and Gestational Hypertension that has completed, run by University of Colorado, Denver. The registered enrollment target is 26 participants, below the 1,126-participant average among 48 other Preeclampsia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02384226, a study of Preeclampsia and Gestational Hypertension, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
Refine content and delivery of the mHealth delivered lifestyle intervention program through iterative testing with small groups of users who provide feedback through on-line asynchronous focus groups.
Primary Outcome
Usability is defined via Young's Mobile Phone Usability Questionnaire (MPUQ) as how easy the app is to use and how easy it is to learn. The investigators will assess components of usability including: 1) learnability (how easy is it to accomplish basic tasks the first time the app is used?); 2) efficiency (once users can use the app, how quickly can they perform tasks?); 3) memorability (if a user returns to an app after not using it for some time, how easy is it to re-establish proficiency?); 4
Conditions Studied
Study Locations (1)
Colorado
- University of Colorado Hospital - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2015-09 |
| Est. Completion | 2020-09 |
What the finished NCT02384226 record still lists
NCT02384226 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,126-participant average among 48 other Preeclampsia trials with a reported enrollment target (98% lower).
The record links to 5 conditions, with Preeclampsia appearing as the primary indexed condition, and to 0 interventions.
NCT02384226 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02384226 about?
NCT02384226 is a clinical study titled "User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study". Refine content and delivery of the mHealth delivered lifestyle intervention program through iterative testing with small groups of users who provide feedback through on-line asynchronous focus groups.
What is the current status of trial NCT02384226?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2015-09. Estimated completion is 2020-09.
What conditions does trial NCT02384226 study?
This clinical trial studies the following conditions: Preeclampsia, Gestational Hypertension, Gestational Diabetes Mellitus, Preterm Delivery, Delivery of Small for Gestational Age (SGA) Baby.
Who is sponsoring clinical trial NCT02384226?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02384226 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02384226's enrollment target sits among peer trials
26 48th of 48 higher than 1 of 48 other Preeclampsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preeclampsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
RECRUITING · Phase 2
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Daily Aspirin Treatment After Preeclampsia
RECRUITING · Early Phase 1
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Exosome Cargo From Preeclampsia Patients
RECRUITING
-
Prenatal Aspirin and Postpartum Vascular Function
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia